{
  "directed": true,
  "graph": {
    "annotation_list": {
      "PublicationStatus": [
        "Published"
      ],
      "PublicationType": [
        "Letter to the Editor"
      ],
      "Section": [
        "Full Text"
      ],
      "mode_of_administration": [
        "intravenous injection"
      ]
    },
    "annotation_pattern": {},
    "annotation_url": {
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20190128.belanno",
      "Species": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Abish K",
      "contact": "abish@causalitybiomodels.com",
      "copyright": "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "COVID Knowledge Curation project",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "32186711.bel",
      "version": "2.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
      "COVID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
      "MESH": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns",
      "TAX": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
    },
    "path": "32186711.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "3626b6b4bc226ee4e704e8713cf73017",
      "line": 47,
      "relation": "decreases",
      "source": 1,
      "target": 18
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "dd133d229f46ebe8aaabfec2adb8d96b",
      "line": 48,
      "relation": "decreases",
      "source": 1,
      "target": 12
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "a355b8b050f7ee59242f2683115eed4d",
      "line": 49,
      "relation": "decreases",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "5e167939b9c718431082bfd380c44608",
      "line": 50,
      "relation": "decreases",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Blood": true,
          "Heart": true,
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "10090": true
        },
        "mode_of_administration": {
          "intravenous injection": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Intravenous infusions of ACEIs and ARBs in experimental animals increase the numbers of angiotensin converting enzyme 2 (ACE2) receptors in the cardiopulmonary circulation. 4",
      "key": "c551b667ed4697a78699f8e41eee7151",
      "line": 61,
      "relation": "increases",
      "source": 1,
      "target": 8
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Blood": true,
          "Heart": true,
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Patients taking ACEIs or ARBs chronically for cardiovascular diseases are assumed to have increased numbers of ACE2 receptors throughout their cardiopulmonary circulations as observed in experimental animal models.",
      "key": "2928f3e5bdee2e70d20825c1fdefcc5b",
      "line": 71,
      "relation": "increases",
      "source": 1,
      "target": 7
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Since patients treated with ACEIs and ARBS will have increased numbers of ACE2 receptors in their lungs for coronavirus S proteins to bind to, they may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.",
      "key": "d687f86305b60a81f434f95ba4e64ad5",
      "line": 92,
      "relation": "increases",
      "source": 1,
      "target": 7
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "8fb0929904786f5db0462b330b0149b2",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 18,
      "target": 9
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "4b72964742d0ee56c70451649af71555",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 9
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "66471e791d6daf5267a3536d20049c87",
      "line": 51,
      "relation": "decreases",
      "source": 0,
      "target": 18
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "cd6f7119bafa820cc83709dfd55004b5",
      "line": 52,
      "relation": "decreases",
      "source": 0,
      "target": 12
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "b897d5c1da71172cf13fd6f8585cee0a",
      "line": 53,
      "relation": "decreases",
      "source": 0,
      "target": 11
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases, such as refractory hypertension, coronary artery disease, heart failure, and post-myocardial infarction status. 1, 2",
      "key": "bef35238ae721e9b069c632ace66fecf",
      "line": 54,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Blood": true,
          "Heart": true,
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "10090": true
        },
        "mode_of_administration": {
          "intravenous injection": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Intravenous infusions of ACEIs and ARBs in experimental animals increase the numbers of angiotensin converting enzyme 2 (ACE2) receptors in the cardiopulmonary circulation. 4",
      "key": "28490637e627eb304a09ce3b4f9f5d49",
      "line": 62,
      "relation": "increases",
      "source": 0,
      "target": 8
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Blood": true,
          "Heart": true,
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Patients taking ACEIs or ARBs chronically for cardiovascular diseases are assumed to have increased numbers of ACE2 receptors throughout their cardiopulmonary circulations as observed in experimental animal models.",
      "key": "14776ec34a29c57e8ed237fe472ba40b",
      "line": 72,
      "relation": "increases",
      "source": 0,
      "target": 7
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Since patients treated with ACEIs and ARBS will have increased numbers of ACE2 receptors in their lungs for coronavirus S proteins to bind to, they may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.",
      "key": "6c41ae44fc40ed3d17fdd0c3736f8fcf",
      "line": 93,
      "relation": "increases",
      "source": 0,
      "target": 7
    },
    {
      "key": "1db03b2523b3b2cd2b465edf9382bc2a",
      "relation": "partOf",
      "source": 7,
      "target": 5
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Since patients treated with ACEIs and ARBS will have increased numbers of ACE2 receptors in their lungs for coronavirus S proteins to bind to, they may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.",
      "key": "9e72cff290f3361f734f8bc97c87bd5d",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 7,
      "target": 5
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Two mechanisms may protect children from COVID-19 infections: (1) cross-protective antibodies from multiple upper respiratory tract infections caused by the common cold-causing alpha coronaviruses, and (2) fewer ACE2 receptors in their lower respiratory tracts to attract the binding S proteins of the beta coronaviruses.",
      "key": "4ac9e028e382e5547c42a81e0f415b83",
      "line": 109,
      "relation": "positiveCorrelation",
      "source": 7,
      "target": 5
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "The phylogenetically related beta coronavirus, SARS-Cov-2, causes the novel coronavirus disease (nCoV-2019) or COVID-19. 5 S proteins anchor both beta coronaviruses to ACE2 receptors in the lower respiratory tract of infected patients in order to gain entry into the lungs.",
      "key": "eded39a2575239da7718b066d11cfd5a",
      "line": 78,
      "relation": "increases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Since patients treated with ACEIs and ARBS will have increased numbers of ACE2 receptors in their lungs for coronavirus S proteins to bind to, they may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.",
      "key": "5c8717f52ff3cf893c53edf8af872bcd",
      "line": 95,
      "relation": "increases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Since patients treated with ACEIs and ARBS will have increased numbers of ACE2 receptors in their lungs for coronavirus S proteins to bind to, they may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.",
      "key": "05e53c47ab1330c332b15c846880d7a4",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 7
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Two mechanisms may protect children from COVID-19 infections: (1) cross-protective antibodies from multiple upper respiratory tract infections caused by the common cold-causing alpha coronaviruses, and (2) fewer ACE2 receptors in their lower respiratory tracts to attract the binding S proteins of the beta coronaviruses.",
      "key": "f978493afc12645fc7ac0d054f24a8c5",
      "line": 109,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 7
    },
    {
      "key": "cc2d182e46a7afcbe8de0b32b4f87ed1",
      "relation": "partOf",
      "source": 6,
      "target": 5
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "The phylogenetically related beta coronavirus, SARS-Cov-2, causes the novel coronavirus disease (nCoV-2019) or COVID-19. 5 S proteins anchor both beta coronaviruses to ACE2 receptors in the lower respiratory tract of infected patients in order to gain entry into the lungs.",
      "key": "6ef8bd2e3f8ffe6c5ea5a5e0ca45d4f3",
      "line": 79,
      "relation": "association",
      "source": 6,
      "target": 3
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Viral pneumonia and potentially fatal respiratory failure may result in susceptible persons after 10-14 days. 5",
      "key": "fe8857babd8f93b1c9f3eb65a1ec6218",
      "line": 85,
      "relation": "increases",
      "source": 9,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Viral pneumonia and potentially fatal respiratory failure may result in susceptible persons after 10-14 days. 5",
      "key": "66cfbad4e8f7a3c3513b406008616bce",
      "line": 86,
      "relation": "increases",
      "source": 9,
      "target": 15
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "3b26972d6ebb8fdfc8216c8431f6ee49",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 18
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "003cd0764f0f7196cc464e444c31aa5a",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 12
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "f0300734b0dd42f713e75ff8a54f55eb",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 13
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "e507f4c46c64e18273b54fcbf7422a5b",
      "line": 102,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 10
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Lung": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "The phylogenetically related beta coronavirus, SARS-Cov-2, causes the novel coronavirus disease (nCoV-2019) or COVID-19. 5 S proteins anchor both beta coronaviruses to ACE2 receptors in the lower respiratory tract of infected patients in order to gain entry into the lungs.",
      "key": "0a528b4f55403b4db5935aaeaa5cbcd0",
      "line": 79,
      "relation": "association",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "e9694a708d6dfa570084ebcfce5a1d7b",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 13,
      "target": 9
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "In this study, Guan et al reported more severe disease outcomes in patients with hypertension, coronary artery disease, diabetes, and chronic renal disease (Table 1). 6",
      "key": "0246ddfed371a4939d4c222da04c3292",
      "line": 102,
      "relation": "positiveCorrelation",
      "source": 10,
      "target": 9
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Two mechanisms may protect children from COVID-19 infections: (1) cross-protective antibodies from multiple upper respiratory tract infections caused by the common cold-causing alpha coronaviruses, and (2) fewer ACE2 receptors in their lower respiratory tracts to attract the binding S proteins of the beta coronaviruses.",
      "key": "89ab314091daeedabd87f33e9ab8b57b",
      "line": 106,
      "relation": "increases",
      "source": 4,
      "target": 16
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Two mechanisms may protect children from COVID-19 infections: (1) cross-protective antibodies from multiple upper respiratory tract infections caused by the common cold-causing alpha coronaviruses, and (2) fewer ACE2 receptors in their lower respiratory tracts to attract the binding S proteins of the beta coronaviruses.",
      "key": "d05aff5963d50fb02b6204dfc38b1af0",
      "line": 107,
      "relation": "increases",
      "source": 16,
      "target": 2
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Letter to the Editor": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Diaz JH"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186711",
        "db_name": "Journal of travel medicine",
        "first": "Diaz JH",
        "last": "Diaz JH"
      },
      "evidence": "Two mechanisms may protect children from COVID-19 infections: (1) cross-protective antibodies from multiple upper respiratory tract infections caused by the common cold-causing alpha coronaviruses, and (2) fewer ACE2 receptors in their lower respiratory tracts to attract the binding S proteins of the beta coronaviruses.",
      "key": "b87c56640d38a3c583d03d7ac1a69186",
      "line": 108,
      "relation": "decreases",
      "source": 2,
      "target": 9
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"angiotensin receptor antagonist\")",
      "concept": {
        "name": "angiotensin receptor antagonist",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "804e9c51456ff53ac97de8fdb426e46e"
    },
    {
      "bel": "a(MESH:\"Angiotensin-Converting Enzyme Inhibitors\")",
      "concept": {
        "name": "Angiotensin-Converting Enzyme Inhibitors",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1421e0d945d1b17a03ff2445854ed2d2"
    },
    {
      "bel": "a(MESH:\"Antibodies, Viral\")",
      "concept": {
        "name": "Antibodies, Viral",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "8a122c80f6b48a193f1f635ab811f71e"
    },
    {
      "bel": "a(TAX:\"Severe acute respiratory syndrome coronavirus 2\")",
      "concept": {
        "name": "Severe acute respiratory syndrome coronavirus 2",
        "namespace": "TAX"
      },
      "function": "Abundance",
      "id": "c41851da59cc36c21b2e8acf24c1f46d"
    },
    {
      "bel": "a(TAX:Alphacoronavirus)",
      "concept": {
        "name": "Alphacoronavirus",
        "namespace": "TAX"
      },
      "function": "Abundance",
      "id": "56b516fd7a9ba2437703a836541e092d"
    },
    {
      "bel": "complex(p(COVID:S), p(HGNC:ACE2))",
      "function": "Complex",
      "id": "6b8514d35b9a04dcfdf30d01d4a3a0a0",
      "members": [
        {
          "bel": "p(COVID:S)",
          "concept": {
            "name": "S",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "8d090715298e11996081058536798c19"
        },
        {
          "bel": "p(HGNC:ACE2)",
          "concept": {
            "name": "ACE2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
        }
      ]
    },
    {
      "bel": "p(COVID:S)",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "8d090715298e11996081058536798c19"
    },
    {
      "bel": "p(HGNC:ACE2)",
      "concept": {
        "name": "ACE2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
    },
    {
      "bel": "p(MGI:Ace2)",
      "concept": {
        "name": "Ace2",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "9cb4733ab4e60addd6378f9f4c97eef9"
    },
    {
      "bel": "path(DO:\"COVID-19\")",
      "concept": {
        "name": "COVID-19",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "6f9f1c2e8012537e503a758c6bfaff0f"
    },
    {
      "bel": "path(DO:\"chronic kidney disease\")",
      "concept": {
        "name": "chronic kidney disease",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "c41e49c1d2c8f2dacb14ef7c3d7c4aca"
    },
    {
      "bel": "path(DO:\"congestive heart failure\")",
      "concept": {
        "name": "congestive heart failure",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "f7be3204e32f0fe982c2db056dff8b4b"
    },
    {
      "bel": "path(DO:\"coronary artery disease\")",
      "concept": {
        "name": "coronary artery disease",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "053309450d0ef006482ac819c8c3469f"
    },
    {
      "bel": "path(DO:\"diabetes mellitus\")",
      "concept": {
        "name": "diabetes mellitus",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "a851751c015aaa69ddfba6458d99c945"
    },
    {
      "bel": "path(DO:\"myocardial infarction\")",
      "concept": {
        "name": "myocardial infarction",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "6452efc38472d39dbe9799180d20fd41"
    },
    {
      "bel": "path(DO:\"respiratory failure\")",
      "concept": {
        "name": "respiratory failure",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "d8af133a6da228e78521eeec3d16b82f"
    },
    {
      "bel": "path(DO:\"upper respiratory tract disease\")",
      "concept": {
        "name": "upper respiratory tract disease",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "465df68f1a59806f1c1d804929d1e366"
    },
    {
      "bel": "path(DO:\"viral pneumonia\")",
      "concept": {
        "name": "viral pneumonia",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "d5680e5b767d58870e63b3f606ac54e9"
    },
    {
      "bel": "path(DO:hypertension)",
      "concept": {
        "name": "hypertension",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "53d5b8bd814074e87b1da1ff6250dcff"
    }
  ]
}